- Home
- OPTT vs CTSO Comparison
OPTT vs CTSO Comparison
Compare OPTT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- CTSO
- Stock Information
- Founded
- OPTT 1984
- CTSO 1997
- Country
- OPTT United States
- CTSO United States
- Employees
- OPTT N/A
- CTSO N/A
- Industry
- OPTT Electric Utilities: Central
- CTSO Medical/Dental Instruments
- Sector
- OPTT Utilities
- CTSO Health Care
- Exchange
- OPTT Nasdaq
- CTSO Nasdaq
- Market Cap
- OPTT 89.7M
- CTSO 72.8M
- IPO Year
- OPTT 2007
- CTSO N/A
- Fundamental
- Price
- OPTT $0.50
- CTSO $0.91
- Analyst Decision
- OPTT
- CTSO Buy
- Analyst Count
- OPTT 0
- CTSO 2
- Target Price
- OPTT N/A
- CTSO $5.50
- AVG Volume (30 Days)
- OPTT 3.8M
- CTSO 379.8K
- Earning Date
- OPTT 09-15-2025
- CTSO 08-07-2025
- Dividend Yield
- OPTT N/A
- CTSO N/A
- EPS Growth
- OPTT N/A
- CTSO N/A
- EPS
- OPTT N/A
- CTSO N/A
- Revenue
- OPTT $5,861,000.00
- CTSO $36,107,520.00
- Revenue This Year
- OPTT N/A
- CTSO $11.15
- Revenue Next Year
- OPTT N/A
- CTSO $21.39
- P/E Ratio
- OPTT N/A
- CTSO N/A
- Revenue Growth
- OPTT 6.08
- CTSO 20.18
- 52 Week Low
- OPTT $0.14
- CTSO $0.71
- 52 Week High
- OPTT $1.75
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- OPTT 45.16
- CTSO 44.06
- Support Level
- OPTT $0.47
- CTSO $0.83
- Resistance Level
- OPTT $0.52
- CTSO $1.19
- Average True Range (ATR)
- OPTT 0.03
- CTSO 0.09
- MACD
- OPTT -0.00
- CTSO -0.01
- Stochastic Oscillator
- OPTT 38.00
- CTSO 21.91
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.